Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Metformin Use in Type 2 Diabetes Mellitus With CKD: Is It Time to Liberalize Dosing Recommendations?

Stanton RC. Metformin Use in Type 2 Diabetes Mellitus With CKD: Is It Time to Liberalize Dosing Recommendations? Am J Kidney Dis. 2015 Aug; 66(2):193-5.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.